Please Note: This trial is no longer enrolling new participants
A Phase I study to determine the safety and tolerability of BI 3820768 in patients with advanced relapsed or refractory germ cell tumours, endometrial cancer, or ovarian cancer
| Protocol No. | CTO-BIPI-2001-0001 | Scope | National |
|---|---|---|---|
| Principal Investigator | Nabil Adra | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
